Compare Davita Inc (DVA) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs HP Inc — how do they compare? Davita Inc trades at $226.14 (market cap $14.92B), while HP Inc trades at $24.28 (market cap $22.52B). The key difference: HP Inc is the larger of the two by market cap, and HP Inc pays a 4.87% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | HPQ | |
|---|---|---|
Market Cap | $14.92B | $22.52B |
Sector | Health | Technology |
52-Week High | $235.71 | $29.35 |
52-Week Low | $103.87 | $18.20 |
Enterprise Value | $27.47B | $29.69B |
Dividend Yield | — | 4.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
HPQ trades at $24.77, up 2.27% today, with a bullish technical outlook and strong earnings momentum, beating estimates for three consecutive quarters. The stock offers a 4.8% dividend yield and trades at attractive valuation multiples, including a P/E of 9.17 and P/S of 0.41. Recent partnerships with OpenAI and Ferrari highlight strategic moves to enhance AI capabilities and innovation in the PC market.
The outlook is positive due to undervaluation, dividend income, and AI-driven growth potential, but risks include PC market volatility, competitive pressures, and reliance on hardware sales. Analyst consensus is mixed with a hold rating, but technical indicators suggest near-term strength with support at $24 and resistance at $25-26.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
